Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study

Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study

The efficacy of the first schedule of COVID-19 mRNA vaccines has decreased after the surge of the Delta variant, posing the need to administer a booster dose to enhance the neutralising immune response. This study aims at evaluating the duration of protection given by the booster dose of Pfizer–BioN...

Full description

Bibliographic Details
Main Authors: Domenico Pascucci, Adriano Grossi, Alberto Lontano, Eleonora Marziali, Mario Cesare Nurchis, Vincenzo Maria Grassi, Matteo Raponi, Giuseppe Vetrugno, Giovanni Capelli, Giovanna Elisa Calabrò, Domenico Staiti, Maurizio Sanguinetti, Gianfranco Damiani, Patrizia Laurenti
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Vaccines
Subjects:
vaccination
SARS-CoV-2
COVID-19
mRNA vaccine
booster
health personnel
Online Access:https://www.mdpi.com/2076-393X/11/1/25

Internet

https://www.mdpi.com/2076-393X/11/1/25

Similar Items